JP2013515019A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515019A5 JP2013515019A5 JP2012545091A JP2012545091A JP2013515019A5 JP 2013515019 A5 JP2013515019 A5 JP 2013515019A5 JP 2012545091 A JP2012545091 A JP 2012545091A JP 2012545091 A JP2012545091 A JP 2012545091A JP 2013515019 A5 JP2013515019 A5 JP 2013515019A5
- Authority
- JP
- Japan
- Prior art keywords
- poloxamer
- polysorbate
- suspension
- surfactant
- particle size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK2009000267 | 2009-12-22 | ||
| DKPCT/DK2009/000267 | 2009-12-22 | ||
| US29309110P | 2010-01-07 | 2010-01-07 | |
| US61/293,091 | 2010-01-07 | ||
| PCT/DK2010/000183 WO2011076208A2 (en) | 2009-12-22 | 2010-12-22 | Calcipotriol monohydrate nanocrystals |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515019A JP2013515019A (ja) | 2013-05-02 |
| JP2013515019A5 true JP2013515019A5 (cg-RX-API-DMAC10.html) | 2013-12-26 |
| JP5816194B2 JP5816194B2 (ja) | 2015-11-18 |
Family
ID=43618145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012545091A Active JP5816194B2 (ja) | 2009-12-22 | 2010-12-22 | カルシポトリオール一水和物ナノクリスタル |
Country Status (15)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2918369C (en) * | 2013-07-18 | 2021-06-29 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| CN105534996B (zh) * | 2016-02-24 | 2018-05-01 | 长沙佰顺生物科技有限公司 | 一种治疗银屑病的药物组合物 |
| KR20190042558A (ko) | 2016-07-05 | 2019-04-24 | 크라토스 엘엘씨 | 부동태화된 예비리튬화된 마이크론 및 서브마이크론 iva족 입자 및 이의 제조방법 |
| US11637280B2 (en) | 2017-03-31 | 2023-04-25 | Kratos LLC | Precharged negative electrode material for secondary battery |
| CN108904445A (zh) * | 2018-08-06 | 2018-11-30 | 江苏知原药业有限公司 | 钙泊三醇纳米悬浮液 |
| CN109157661B (zh) * | 2018-09-10 | 2021-09-24 | 南京工业大学 | 一种配体辅助下用氧化物silica包覆疏水性分子晶体的方法 |
| RU2749360C1 (ru) * | 2020-10-09 | 2021-06-09 | Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) | Способ лечения ладонно-подошвенного пустулеза |
| JP7751298B2 (ja) * | 2021-07-14 | 2025-10-08 | 株式会社ツツミプランニング | 浸透深さの調整方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8315787D0 (en) * | 1983-06-08 | 1983-07-13 | Briggs J H | Coolant spray |
| US4758432A (en) * | 1984-10-15 | 1988-07-19 | Richardson-Vicks Inc. | Topical treatment of skin inflammatory disorders |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| GB9300763D0 (en) * | 1993-01-15 | 1993-03-03 | Leo Pharm Prod Ltd | Chemical compound |
| DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
| GB9504265D0 (en) * | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
| US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
| DE19932157A1 (de) | 1999-07-13 | 2001-01-18 | Pharmasol Gmbh | Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln |
| US6403654B1 (en) * | 2000-04-13 | 2002-06-11 | Mariana De Oliveira | Compositions for and method of treatment for psoriasis |
| PL212660B1 (pl) * | 2000-10-27 | 2012-11-30 | Leo Pharma As | Zasadniczo niewodna zelowa kompozycja farmaceutyczna do podawania na skóre oraz jej zastosowanie |
| EP1339390A2 (en) * | 2000-12-06 | 2003-09-03 | Pharmacia Corporation | Laboratory scale milling process |
| FR2834212B1 (fr) * | 2001-12-27 | 2004-07-09 | Besins Int Belgique | Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques |
| CA2509101A1 (en) | 2002-12-13 | 2004-07-01 | Jagotec Ag | A topical nanoparticulate spironolactone formulation |
| CA2530302C (en) | 2003-07-24 | 2013-12-03 | Leo Pharma A/S | Novel aminobenzophenone compounds |
| EP1742612A2 (en) * | 2004-05-06 | 2007-01-17 | Ivrea Pharmaceuticals, Inc. | Particles for the delivery of active agents |
| US20060110415A1 (en) * | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
| ES2341473T3 (es) | 2004-12-13 | 2010-06-21 | Leo Pharma A/S | Compuestos de aminobenzofenona sustituida con triazol. |
| ES2447301T3 (es) * | 2005-06-01 | 2014-03-11 | Glaxosmithkline Intellectual Property Development Limited | Formulación vitamínica |
| WO2007050543A2 (en) * | 2005-10-24 | 2007-05-03 | Collegium Pharmaceutical, Inc. | Topical pharmaceutical foam composition |
| AU2007264418B2 (en) * | 2006-06-30 | 2012-05-03 | Iceutica Pty Ltd | Methods for the preparation of biologically active compounds in nanoparticulate form |
| WO2008058755A1 (en) * | 2006-11-17 | 2008-05-22 | Abbott Gmbh & Co. Kg | Nanocrystals for use in topical cosmetic formulations and method of production thereof |
| HRP20110464T1 (hr) | 2006-12-22 | 2011-07-31 | Leo Pharma A/S | Supstituirani acetofenoni korisni kao inhibitori pde4 |
| SI2114951T1 (sl) | 2007-02-28 | 2014-08-29 | Leo Pharma A/S | Novi zaviralci fosfodiesteraze |
| CN101677979A (zh) | 2007-04-19 | 2010-03-24 | 利奥制药有限公司 | Src家族激酶抑制剂 |
| EP2146780A1 (en) | 2007-05-11 | 2010-01-27 | Sonneborn Inc. | Petrolatums having silicone-like properties |
| WO2010069322A1 (en) | 2008-12-19 | 2010-06-24 | Leo Pharma A/S | Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
-
2010
- 2010-12-22 NZ NZ601000A patent/NZ601000A/en unknown
- 2010-12-22 CN CN201080064526.6A patent/CN102770125B/zh active Active
- 2010-12-22 MX MX2012007234A patent/MX2012007234A/es active IP Right Grant
- 2010-12-22 US US13/518,214 patent/US20130039952A1/en not_active Abandoned
- 2010-12-22 WO PCT/DK2010/000183 patent/WO2011076208A2/en not_active Ceased
- 2010-12-22 CA CA2785253A patent/CA2785253A1/en not_active Abandoned
- 2010-12-22 RU RU2012130412/15A patent/RU2555339C2/ru active
- 2010-12-22 PL PL10803440T patent/PL2515874T3/pl unknown
- 2010-12-22 EP EP10803440.6A patent/EP2515874B1/en active Active
- 2010-12-22 ES ES10803440.6T patent/ES2523119T3/es active Active
- 2010-12-22 BR BR112012015449-4A patent/BR112012015449B1/pt active IP Right Grant
- 2010-12-22 JP JP2012545091A patent/JP5816194B2/ja active Active
- 2010-12-22 AU AU2010335655A patent/AU2010335655B2/en active Active
-
2012
- 2012-06-19 IL IL220516A patent/IL220516A/en active IP Right Grant
- 2012-06-21 ZA ZA2012/04618A patent/ZA201204618B/en unknown
-
2014
- 2014-03-20 US US14/220,843 patent/US20140322331A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515019A5 (cg-RX-API-DMAC10.html) | ||
| CN109963555A (zh) | 一种包含美洛昔康的可注射的药物组合物及其制备方法 | |
| WO2012177886A3 (en) | Process of forming crystals for use in a personal care composition | |
| EP3495446A3 (en) | Particles containing one or more controlled release cross-linked active agents | |
| MX2023004255A (es) | Comprimidos que comprenden 2-hidroxi-6-((2-(1-isopropil-1h-pirazol -5-il)piridin-3-il)metoxi)benzaldehido. | |
| WO2012051426A3 (en) | Aggregate nanoparticulate medicament formulations, manufacture and use thereof | |
| NZ728721A (en) | Pharmaceutical nanoparticles showing improved mucosal transport | |
| WO2007107571A3 (en) | Casting process | |
| Jakubowska et al. | Freeze-drying of drug nanosuspension–study of formulation and processing factors for the optimization and characterization of redispersible cilostazol nanocrystals | |
| AR067747A1 (es) | Metodos para producir suspension de aripiprazol y formulacion liofilizada | |
| RU2017108432A (ru) | Жидкая ингаляционная композиция, содержащая rpl 554 | |
| WO2011063990A3 (en) | Spider silk particles for controlled and sustained delivery of compounds | |
| JP2010514660A5 (cg-RX-API-DMAC10.html) | ||
| MX2018011190A (es) | Cuerpo de dispersion de particulas finas de material de proteccion de infrarrojo cercano, cuerpo de proteccion de infrarrojo cercano y estructura laminada de proteccion de infrarrojo cercano y metodo de produccion de los mismos. | |
| CN102488920B (zh) | 核壳结构的α-半水硫酸钙/羟基磷灰石复合颗粒及制备 | |
| WO2013132457A3 (en) | Nanocrystalline solid dispersion compositions and process of preparation thereof | |
| WO2017177004A8 (en) | Tertiary amides and method of use | |
| NZ601000A (en) | Calcipotriol monohydrate nanocrystals | |
| Yu et al. | Porous Al2O3 microspheres prepared by a novel ice-templated spray drying technique | |
| Dong et al. | Clay as a matrix former for spray drying of drug nanosuspensions | |
| HK1214951A1 (zh) | 眼用製劑 | |
| RU2018120170A (ru) | Физически и химически стабильные пероральные суспензии гивиностата | |
| RU2016112178A (ru) | Способ получения композиции для личной гигиены с использованием уплотненных модификаторов реологии | |
| WO2013025442A3 (en) | Concentrated felbamate formulations for parenteral administration | |
| MX359554B (es) | Microesferas cristalinas y proceso para fabricacion de las mismas. |